BioCentury
ARTICLE | Clinical News

Niraparib: Additional Phase III data

October 17, 2016 7:00 AM UTC

Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. Zai Lab Ltd., Shanghai, China Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Niraparib (MK-4827) Business: Cancer Molecular target: Poly(ADP-ribose)...